-
1
-
-
84929896699
-
Antibody responses to envelope glycoproteins in HIV-1 infection
-
Burton, D.R., Mascola, J.R., Antibody responses to envelope glycoproteins in HIV-1 infection. Nat. Immunol. 16 (2015), 571–576.
-
(2015)
Nat. Immunol.
, vol.16
, pp. 571-576
-
-
Burton, D.R.1
Mascola, J.R.2
-
2
-
-
84930365226
-
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
-
Crooks, E.T., Tong, T., Chakrabarti, B., Narayan, K., Georgiev, I.S., Menis, S., Huang, X., Kulp, D., Osawa, K., Muranaka, J., et al. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site. PLoS Pathog., 11, 2015, e1004932.
-
(2015)
PLoS Pathog.
, vol.11
, pp. e1004932
-
-
Crooks, E.T.1
Tong, T.2
Chakrabarti, B.3
Narayan, K.4
Georgiev, I.S.5
Menis, S.6
Huang, X.7
Kulp, D.8
Osawa, K.9
Muranaka, J.10
-
3
-
-
79251480393
-
Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain
-
Das, S.R., Puigbò, P., Hensley, S.E., Hurt, D.E., Bennink, J.R., Yewdell, J.W., Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog., 6, 2010, e1001211.
-
(2010)
PLoS Pathog.
, vol.6
, pp. e1001211
-
-
Das, S.R.1
Puigbò, P.2
Hensley, S.E.3
Hurt, D.E.4
Bennink, J.R.5
Yewdell, J.W.6
-
4
-
-
82755184131
-
Increasing the potency and breadth of an HIV antibody by using structure-based rational design
-
Diskin, R., Scheid, J.F., Marcovecchio, P.M., West, A.P. Jr., Klein, F., Gao, H., Gnanapragasam, P.N., Abadir, A., Seaman, M.S., Nussenzweig, M.C., Bjorkman, P.J., Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334 (2011), 1289–1293.
-
(2011)
Science
, vol.334
, pp. 1289-1293
-
-
Diskin, R.1
Scheid, J.F.2
Marcovecchio, P.M.3
West, A.P.4
Klein, F.5
Gao, H.6
Gnanapragasam, P.N.7
Abadir, A.8
Seaman, M.S.9
Nussenzweig, M.C.10
Bjorkman, P.J.11
-
5
-
-
84879523938
-
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies
-
Diskin, R., Klein, F., Horwitz, J.A., Halper-Stromberg, A., Sather, D.N., Marcovecchio, P.M., Lee, T., West, A.P. Jr., Gao, H., Seaman, M.S., et al. Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies. J. Exp. Med. 210 (2013), 1235–1249.
-
(2013)
J. Exp. Med.
, vol.210
, pp. 1235-1249
-
-
Diskin, R.1
Klein, F.2
Horwitz, J.A.3
Halper-Stromberg, A.4
Sather, D.N.5
Marcovecchio, P.M.6
Lee, T.7
West, A.P.8
Gao, H.9
Seaman, M.S.10
-
6
-
-
73949084963
-
Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables
-
Doria-Rose, N.A., Klein, R.M., Daniels, M.G., O'Dell, S., Nason, M., Lapedes, A., Bhattacharya, T., Migueles, S.A., Wyatt, R.T., Korber, B.T., et al. Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables. J. Virol. 84 (2010), 1631–1636.
-
(2010)
J. Virol.
, vol.84
, pp. 1631-1636
-
-
Doria-Rose, N.A.1
Klein, R.M.2
Daniels, M.G.3
O'Dell, S.4
Nason, M.5
Lapedes, A.6
Bhattacharya, T.7
Migueles, S.A.8
Wyatt, R.T.9
Korber, B.T.10
-
7
-
-
84899991983
-
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
-
Doria-Rose, N.A., Schramm, C.A., Gorman, J., Moore, P.L., Bhiman, J.N., DeKosky, B.J., Ernandes, M.J., Georgiev, I.S., Kim, H.J., Pancera, M., et al., NISC Comparative Sequencing Program. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 509 (2014), 55–62.
-
(2014)
Nature
, vol.509
, pp. 55-62
-
-
Doria-Rose, N.A.1
Schramm, C.A.2
Gorman, J.3
Moore, P.L.4
Bhiman, J.N.5
DeKosky, B.J.6
Ernandes, M.J.7
Georgiev, I.S.8
Kim, H.J.9
Pancera, M.10
-
8
-
-
84905369598
-
Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies
-
Gao, F., Bonsignori, M., Liao, H.X., Kumar, A., Xia, S.M., Lu, X., Cai, F., Hwang, K.K., Song, H., Zhou, T., et al. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell 158 (2014), 481–491.
-
(2014)
Cell
, vol.158
, pp. 481-491
-
-
Gao, F.1
Bonsignori, M.2
Liao, H.X.3
Kumar, A.4
Xia, S.M.5
Lu, X.6
Cai, F.7
Hwang, K.K.8
Song, H.9
Zhou, T.10
-
9
-
-
84963620358
-
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans
-
Garces, F., Lee, J.H., de Val, N., de la Pena, A.T., Kong, L., Puchades, C., Hua, Y., Stanfield, R.L., Burton, D.R., Moore, J.P., et al. Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. Immunity 43 (2015), 1053–1063.
-
(2015)
Immunity
, vol.43
, pp. 1053-1063
-
-
Garces, F.1
Lee, J.H.2
de Val, N.3
de la Pena, A.T.4
Kong, L.5
Puchades, C.6
Hua, Y.7
Stanfield, R.L.8
Burton, D.R.9
Moore, J.P.10
-
10
-
-
84877618448
-
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization
-
Georgiev, I.S., Doria-Rose, N.A., Zhou, T., Kwon, Y.D., Staupe, R.P., Moquin, S., Chuang, G.Y., Louder, M.K., Schmidt, S.D., Altae-Tran, H.R., et al. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Science 340 (2013), 751–756.
-
(2013)
Science
, vol.340
, pp. 751-756
-
-
Georgiev, I.S.1
Doria-Rose, N.A.2
Zhou, T.3
Kwon, Y.D.4
Staupe, R.P.5
Moquin, S.6
Chuang, G.Y.7
Louder, M.K.8
Schmidt, S.D.9
Altae-Tran, H.R.10
-
11
-
-
84930948323
-
New approaches to HIV vaccine development
-
Haynes, B.F., New approaches to HIV vaccine development. Curr. Opin. Immunol. 35 (2015), 39–47.
-
(2015)
Curr. Opin. Immunol.
, vol.35
, pp. 39-47
-
-
Haynes, B.F.1
-
12
-
-
78049514276
-
Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions
-
Helle, F., Vieyres, G., Elkrief, L., Popescu, C.I., Wychowski, C., Descamps, V., Castelain, S., Roingeard, P., Duverlie, G., Dubuisson, J., Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. J. Virol. 84 (2010), 11905–11915.
-
(2010)
J. Virol.
, vol.84
, pp. 11905-11915
-
-
Helle, F.1
Vieyres, G.2
Elkrief, L.3
Popescu, C.I.4
Wychowski, C.5
Descamps, V.6
Castelain, S.7
Roingeard, P.8
Duverlie, G.9
Dubuisson, J.10
-
13
-
-
84884991510
-
Isolation of human monoclonal antibodies from peripheral blood B cells
-
Huang, J., Doria-Rose, N.A., Longo, N.S., Laub, L., Lin, C.L., Turk, E., Kang, B.H., Migueles, S.A., Bailer, R.T., Mascola, J.R., Connors, M., Isolation of human monoclonal antibodies from peripheral blood B cells. Nat. Protoc. 8 (2013), 1907–1915.
-
(2013)
Nat. Protoc.
, vol.8
, pp. 1907-1915
-
-
Huang, J.1
Doria-Rose, N.A.2
Longo, N.S.3
Laub, L.4
Lin, C.L.5
Turk, E.6
Kang, B.H.7
Migueles, S.A.8
Bailer, R.T.9
Mascola, J.R.10
Connors, M.11
-
14
-
-
84911947017
-
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
-
Klein, F., Nogueira, L., Nishimura, Y., Phad, G., West, A.P. Jr., Halper-Stromberg, A., Horwitz, J.A., Gazumyan, A., Liu, C., Eisenreich, T.R., et al. Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. J. Exp. Med. 211 (2014), 2361–2372.
-
(2014)
J. Exp. Med.
, vol.211
, pp. 2361-2372
-
-
Klein, F.1
Nogueira, L.2
Nishimura, Y.3
Phad, G.4
West, A.P.5
Halper-Stromberg, A.6
Horwitz, J.A.7
Gazumyan, A.8
Liu, C.9
Eisenreich, T.R.10
-
15
-
-
23244434512
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
-
Li, M., Gao, F., Mascola, J.R., Stamatatos, L., Polonis, V.R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K.M., et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79 (2005), 10108–10125.
-
(2005)
J. Virol.
, vol.79
, pp. 10108-10125
-
-
Li, M.1
Gao, F.2
Mascola, J.R.3
Stamatatos, L.4
Polonis, V.R.5
Koutsoukos, M.6
Voss, G.7
Goepfert, P.8
Gilbert, P.9
Greene, K.M.10
-
16
-
-
80052287270
-
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01
-
Li, Y., O'Dell, S., Walker, L.M., Wu, X., Guenaga, J., Feng, Y., Schmidt, S.D., McKee, K., Louder, M.K., Ledgerwood, J.E., et al. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J. Virol. 85 (2011), 8954–8967.
-
(2011)
J. Virol.
, vol.85
, pp. 8954-8967
-
-
Li, Y.1
O'Dell, S.2
Walker, L.M.3
Wu, X.4
Guenaga, J.5
Feng, Y.6
Schmidt, S.D.7
McKee, K.8
Louder, M.K.9
Ledgerwood, J.E.10
-
17
-
-
84919430580
-
Polyreactivity and autoreactivity among HIV-1 antibodies
-
Liu, M., Yang, G., Wiehe, K., Nicely, N.I., Vandergrift, N.A., Rountree, W., Bonsignori, M., Alam, S.M., Gao, J., Haynes, B.F., Kelsoe, G., Polyreactivity and autoreactivity among HIV-1 antibodies. J. Virol. 89 (2015), 784–798.
-
(2015)
J. Virol.
, vol.89
, pp. 784-798
-
-
Liu, M.1
Yang, G.2
Wiehe, K.3
Nicely, N.I.4
Vandergrift, N.A.5
Rountree, W.6
Bonsignori, M.7
Alam, S.M.8
Gao, J.9
Haynes, B.F.10
Kelsoe, G.11
-
18
-
-
84925431182
-
HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies
-
Lynch, R.M., Wong, P., Tran, L., O'Dell, S., Nason, M.C., Li, Y., Wu, X., Mascola, J.R., HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies. J. Virol. 89 (2015), 4201–4213.
-
(2015)
J. Virol.
, vol.89
, pp. 4201-4213
-
-
Lynch, R.M.1
Wong, P.2
Tran, L.3
O'Dell, S.4
Nason, M.C.5
Li, Y.6
Wu, X.7
Mascola, J.R.8
-
19
-
-
84967148279
-
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch
-
MacLeod, D.T., Choi, N.M., Briney, B., Garces, F., Ver, L.S., Landais, E., Murrell, B., Wrin, T., Kilembe, W., Liang, C.H., et al., IAVI Protocol C Investigators & The IAVI African HIV Research Network. Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch. Immunity 44 (2016), 1215–1226.
-
(2016)
Immunity
, vol.44
, pp. 1215-1226
-
-
MacLeod, D.T.1
Choi, N.M.2
Briney, B.3
Garces, F.4
Ver, L.S.5
Landais, E.6
Murrell, B.7
Wrin, T.8
Kilembe, W.9
Liang, C.H.10
-
20
-
-
84869155712
-
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
-
Moore, P.L., Gray, E.S., Wibmer, C.K., Bhiman, J.N., Nonyane, M., Sheward, D.J., Hermanus, T., Bajimaya, S., Tumba, N.L., Abrahams, M.R., et al. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat. Med. 18 (2012), 1688–1692.
-
(2012)
Nat. Med.
, vol.18
, pp. 1688-1692
-
-
Moore, P.L.1
Gray, E.S.2
Wibmer, C.K.3
Bhiman, J.N.4
Nonyane, M.5
Sheward, D.J.6
Hermanus, T.7
Bajimaya, S.8
Tumba, N.L.9
Abrahams, M.R.10
-
21
-
-
84922225958
-
Rapid development of broadly influenza neutralizing antibodies through redundant mutations
-
Pappas, L., Foglierini, M., Piccoli, L., Kallewaard, N.L., Turrini, F., Silacci, C., Fernandez-Rodriguez, B., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G., et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516 (2014), 418–422.
-
(2014)
Nature
, vol.516
, pp. 418-422
-
-
Pappas, L.1
Foglierini, M.2
Piccoli, L.3
Kallewaard, N.L.4
Turrini, F.5
Silacci, C.6
Fernandez-Rodriguez, B.7
Agatic, G.8
Giacchetto-Sasselli, I.9
Pellicciotta, G.10
-
22
-
-
0037389643
-
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
-
Richman, D.D., Wrin, T., Little, S.J., Petropoulos, C.J., Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100 (2003), 4144–4149.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 4144-4149
-
-
Richman, D.D.1
Wrin, T.2
Little, S.J.3
Petropoulos, C.J.4
-
23
-
-
84907971356
-
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo
-
Rudicell, R.S., Kwon, Y.D., Ko, S.Y., Pegu, A., Louder, M.K., Georgiev, I.S., Wu, X., Zhu, J., Boyington, J.C., Chen, X., et al., NISC Comparative Sequencing Program. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo. J. Virol. 88 (2014), 12669–12682.
-
(2014)
J. Virol.
, vol.88
, pp. 12669-12682
-
-
Rudicell, R.S.1
Kwon, Y.D.2
Ko, S.Y.3
Pegu, A.4
Louder, M.K.5
Georgiev, I.S.6
Wu, X.7
Zhu, J.8
Boyington, J.C.9
Chen, X.10
-
24
-
-
84988698013
-
Determinants of HIV-1 broadly neutralizing antibody induction
-
advance online publication
-
Rusert, P., Kouyos, R.D., Kadelka, C., Ebner, H., Schanz, M., Huber, M., Braun, D.L., Hozé, N., Scherrer, A., Magnus, C., et al., Swiss HIV Cohort Study. Determinants of HIV-1 broadly neutralizing antibody induction. Nat. Med., 2016 advance online publication.
-
(2016)
Nat. Med.
-
-
Rusert, P.1
Kouyos, R.D.2
Kadelka, C.3
Ebner, H.4
Schanz, M.5
Huber, M.6
Braun, D.L.7
Hozé, N.8
Scherrer, A.9
Magnus, C.10
-
25
-
-
58149487645
-
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
-
Sather, D.N., Armann, J., Ching, L.K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., Stamatatos, L., Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83 (2009), 757–769.
-
(2009)
J. Virol.
, vol.83
, pp. 757-769
-
-
Sather, D.N.1
Armann, J.2
Ching, L.K.3
Mavrantoni, A.4
Sellhorn, G.5
Caldwell, Z.6
Yu, X.7
Wood, B.8
Self, S.9
Kalams, S.10
Stamatatos, L.11
-
26
-
-
84928564663
-
Antibody engineering for increased potency, breadth and half-life
-
Sievers, S.A., Scharf, L., West, A.P. Jr., Bjorkman, P.J., Antibody engineering for increased potency, breadth and half-life. Curr. Opin. HIV AIDS 10 (2015), 151–159.
-
(2015)
Curr. Opin. HIV AIDS
, vol.10
, pp. 151-159
-
-
Sievers, S.A.1
Scharf, L.2
West, A.P.3
Bjorkman, P.J.4
-
27
-
-
67650453747
-
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm
-
Simek, M.D., Rida, W., Priddy, F.H., Pung, P., Carrow, E., Laufer, D.S., Lehrman, J.K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J. Virol. 83 (2009), 7337–7348.
-
(2009)
J. Virol.
, vol.83
, pp. 7337-7348
-
-
Simek, M.D.1
Rida, W.2
Priddy, F.H.3
Pung, P.4
Carrow, E.5
Laufer, D.S.6
Lehrman, J.K.7
Boaz, M.8
Tarragona-Fiol, T.9
Miiro, G.10
-
28
-
-
84948964373
-
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection
-
Sommerstein, R., Flatz, L., Remy, M.M., Malinge, P., Magistrelli, G., Fischer, N., Sahin, M., Bergthaler, A., Igonet, S., Ter Meulen, J., et al. Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection. PLoS Pathog., 11, 2015, e1005276.
-
(2015)
PLoS Pathog.
, vol.11
, pp. e1005276
-
-
Sommerstein, R.1
Flatz, L.2
Remy, M.M.3
Malinge, P.4
Magistrelli, G.5
Fischer, N.6
Sahin, M.7
Bergthaler, A.8
Igonet, S.9
Ter Meulen, J.10
-
29
-
-
84959481369
-
Broadly Neutralizing Antibodies for HIV Eradication
-
Stephenson, K.E., Barouch, D.H., Broadly Neutralizing Antibodies for HIV Eradication. Curr. HIV/AIDS Rep. 13 (2016), 31–37.
-
(2016)
Curr. HIV/AIDS Rep.
, vol.13
, pp. 31-37
-
-
Stephenson, K.E.1
Barouch, D.H.2
-
30
-
-
84963936310
-
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
-
Stewart-Jones, G.B., Soto, C., Lemmin, T., Chuang, G.Y., Druz, A., Kong, R., Thomas, P.V., Wagh, K., Zhou, T., Behrens, A.J., et al. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G. Cell 165 (2016), 813–826.
-
(2016)
Cell
, vol.165
, pp. 813-826
-
-
Stewart-Jones, G.B.1
Soto, C.2
Lemmin, T.3
Chuang, G.Y.4
Druz, A.5
Kong, R.6
Thomas, P.V.7
Wagh, K.8
Zhou, T.9
Behrens, A.J.10
-
31
-
-
33750576972
-
Structure of the Epstein-Barr virus major envelope glycoprotein
-
Szakonyi, G., Klein, M.G., Hannan, J.P., Young, K.A., Ma, R.Z., Asokan, R., Holers, V.M., Chen, X.S., Structure of the Epstein-Barr virus major envelope glycoprotein. Nat. Struct. Mol. Biol. 13 (2006), 996–1001.
-
(2006)
Nat. Struct. Mol. Biol.
, vol.13
, pp. 996-1001
-
-
Szakonyi, G.1
Klein, M.G.2
Hannan, J.P.3
Young, K.A.4
Ma, R.Z.5
Asokan, R.6
Holers, V.M.7
Chen, X.S.8
-
32
-
-
0037456827
-
Antibody neutralization and escape by HIV-1
-
Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F., Salazar, M.G., Kilby, J.M., Saag, M.S., et al. Antibody neutralization and escape by HIV-1. Nature 422 (2003), 307–312.
-
(2003)
Nature
, vol.422
, pp. 307-312
-
-
Wei, X.1
Decker, J.M.2
Wang, S.3
Hui, H.4
Kappes, J.C.5
Wu, X.6
Salazar-Gonzalez, J.F.7
Salazar, M.G.8
Kilby, J.M.9
Saag, M.S.10
-
33
-
-
84887270287
-
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes
-
Wibmer, C.K., Bhiman, J.N., Gray, E.S., Tumba, N., Abdool Karim, S.S., Williamson, C., Morris, L., Moore, P.L., Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. PLoS Pathog., 9, 2013, e1003738.
-
(2013)
PLoS Pathog.
, vol.9
, pp. e1003738
-
-
Wibmer, C.K.1
Bhiman, J.N.2
Gray, E.S.3
Tumba, N.4
Abdool Karim, S.S.5
Williamson, C.6
Morris, L.7
Moore, P.L.8
-
34
-
-
84861313139
-
Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site
-
Wu, X., Wang, C., O'Dell, S., Li, Y., Keele, B.F., Yang, Z., Imamichi, H., Doria-Rose, N., Hoxie, J.A., Connors, M., et al. Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site. J. Virol. 86 (2012), 5844–5856.
-
(2012)
J. Virol.
, vol.86
, pp. 5844-5856
-
-
Wu, X.1
Wang, C.2
O'Dell, S.3
Li, Y.4
Keele, B.F.5
Yang, Z.6
Imamichi, H.7
Doria-Rose, N.8
Hoxie, J.A.9
Connors, M.10
-
35
-
-
84937761089
-
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection
-
Wu, X., Zhang, Z., Schramm, C.A., Joyce, M.G., Kwon, Y.D., Zhou, T., Sheng, Z., Zhang, B., O'Dell, S., McKee, K., et al., NISC Comparative Sequencing Program. Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection. Cell 161 (2015), 470–485.
-
(2015)
Cell
, vol.161
, pp. 470-485
-
-
Wu, X.1
Zhang, Z.2
Schramm, C.A.3
Joyce, M.G.4
Kwon, Y.D.5
Zhou, T.6
Sheng, Z.7
Zhang, B.8
O'Dell, S.9
McKee, K.10
-
36
-
-
84882589754
-
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies
-
Zhou, T., Zhu, J., Wu, X., Moquin, S., Zhang, B., Acharya, P., Georgiev, I.S., Altae-Tran, H.R., Chuang, G.Y., Joyce, M.G., et al., NISC Comparative Sequencing Program. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39 (2013), 245–258.
-
(2013)
Immunity
, vol.39
, pp. 245-258
-
-
Zhou, T.1
Zhu, J.2
Wu, X.3
Moquin, S.4
Zhang, B.5
Acharya, P.6
Georgiev, I.S.7
Altae-Tran, H.R.8
Chuang, G.Y.9
Joyce, M.G.10
-
37
-
-
84930418589
-
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
-
Zhou, T., Lynch, R.M., Chen, L., Acharya, P., Wu, X., Doria-Rose, N.A., Joyce, M.G., Lingwood, D., Soto, C., Bailer, R.T., et al., NISC Comparative Sequencing Program. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors. Cell 161 (2015), 1280–1292.
-
(2015)
Cell
, vol.161
, pp. 1280-1292
-
-
Zhou, T.1
Lynch, R.M.2
Chen, L.3
Acharya, P.4
Wu, X.5
Doria-Rose, N.A.6
Joyce, M.G.7
Lingwood, D.8
Soto, C.9
Bailer, R.T.10
-
38
-
-
4344670467
-
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein
-
Zlateva, K.T., Lemey, P., Vandamme, A.M., Van Ranst, M., Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. J. Virol. 78 (2004), 4675–4683.
-
(2004)
J. Virol.
, vol.78
, pp. 4675-4683
-
-
Zlateva, K.T.1
Lemey, P.2
Vandamme, A.M.3
Van Ranst, M.4
|